Press Release
OncoHealth Secures Strategic Investments from Arsenal Capital Partners & McKesson Corporation
Investment to Accelerate Continued Innovation of Its Digital-First, Oncology Platform
Read morePress Release
EY Names OncoHealth CEO Rick Dean As an Entrepreneur Of The Year® 2022 Southeast Award Finalist
Ernst & Young LLP (EY US) announced that Rick Dean, CEO of OncoHealth has been named an Entrepreneur Of The Year® 2022 Southeast Award finalist
Read morePress Release
OncoHealth Launches New Consumer Platform Bringing Digital Telehealth Services to People with Cancer
OncoHealth Collaborates with Three Innovative Health Plans to Deliver Personalized Supportive Care
Read morePress Release
OncoHealth Named One of the Top Workplaces for 2022 by The Atlanta Journal-Constitution
Atlanta, GA, March 14, 2022 — OncoHealth, a leading digital health company dedicated to oncology, has been awarded a Top Workplaces 2022 honor by The Atlanta…
Read morePress Release
OncoHealth Continues Significant Revenue, Membership, Employee Growth and Innovation in Successful 2021
Company increased YOY revenue by 43%, delivered $120 million of financial impact to clients and added 1.2 million new members to its digital oncology platform
Read morePress Release
OncoHealth Announces Three C-Suite Promotions
Shay Hurst named Chief People Officer, Sara Zywicki named Chief Product Officer, Kathy Mosbaugh named Chief Customer Officer
Read morePress Release
OncoHealth’s Analysis of the FDA’s H2 2021 Drug Approval Activity Shows Largest Number of Oncology Accelerated Approval Withdrawals in 11 Years
Report also reveals a 35% increase in cancer indication approvals, and a 5x rise in pre- and postoperative approvals in the curative-intent setting
Read morePress Release
OncoHealth Report on the FDA’s Q2 2021 Oncology Drug Approvals Shows Continued Rise in Accelerated Approvals
Quarterly report also reveals 29% of approvals contained an immune checkpoint inhibitor and 43% were biomarker dependent
Read morePress Release
Oncology Analytics Announces Rebrand to OncoHealth
New name comes on the heels of major growth period and reflects the company’s expanding digital health portfolio
Read morePress Release
OncoHealth Releases Report on FDA’s Q1 2021 Drug and Indications Approvals
Report shows 75% increase in new drug approvals compared to Q4 2020; Over 35% granted accelerated approval by the FDA
Read morePress Release
Ongoing Innovation, Patient-First Approach Drives Successful 2020 for OncoHealth
Company increased revenue YOY by 40%, delivered over $100 million of financial impact to clients, and added 1.1 million incremental new members on prior auth platform
Read morePress Release
Harvard Pilgrim Health Care Partners With OncoHealth for Oncology Benefits Management
Harvard Pilgrim Implements Real-World Data-Driven Prior Authorization Solution That Leverages Both Clinical and Claims Data
Read more











